India Pharma ExportTrusted Medicines. Healthier Tomorrow.
Tier 3 — Emerging (with Tier 2 South Africa)

Pharma Export to Africa from India

Africa is the highest-volume, most accessible corridor for Indian pharmaceutical exports and the recommended starting market for a new exporter. Registration bodies such as NAFDAC (Nigeria), the Pharmacy and Poisons Board (Kenya) and TMDA (Tanzania) generally accept a WHO-GMP certificate and Certificate of Pharmaceutical Product (COPP) from an Indian manufacturing partner without requiring your own inspected facility.

Countries: Nigeria, Kenya, Tanzania, Ghana, Uganda, Ethiopia, South Africa

What Sells in This Market

Antiretrovirals (ARVs)AntimalarialsAnti-TB medicinesBroad-spectrum antibioticsEssential medicines for hospital tenders

Regulatory Pathway

Pathway

NAFDAC (Nigeria), PPB (Kenya), TMDA (Tanzania), and equivalent national regulators. Dossier is typically CTD-lite plus a COPP and free-sale certificate.

Plant Requirement

WHO-GMP certification plus COPP from the manufacturing partner is generally sufficient. WHO Prequalification (WHO PQ) unlocks Global Fund, PEPFAR, UNICEF and Gavi tender procurement — the single highest-leverage certification for this corridor.

Timeline

4–18 months per product registration, plus local agent appointment

Barrier to Entry

Low to medium

Regulatory Considerations

  • Each destination country registers each product separately — dossier, samples, fees and a local agent are required per country
  • Several destinations now require an antibiotic-specific import permit under antimicrobial stewardship rules
  • WHO Prequalification is close to mandatory for donor-funded ARV, antimalarial and anti-TB tenders
  • Products withdrawn or banned in other markets (e.g. some fixed-dose combinations) are checked against each destination's own register, not assumed safe because they are approved in India

Documentation

  • Commercial invoice
  • Packing list
  • Certificate of Origin
  • Certificate of Analysis
  • Certificate of Pharmaceutical Product (COPP)
  • Free Sale Certificate
  • GMP certificate of the manufacturing plant
  • Import permit of the buyer

Market Opportunity

Africa buys the categories India is strongest in — ARVs, antimalarials, anti-TB medicines, antibiotics and essential-medicine generics — largely through donor-funded and government-tender channels rather than open retail. This is where the handbook's own guidance recommends a new merchant exporter start.

Frequently Asked Questions

Yes. Africa is widely regarded as the most accessible corridor for a new merchant exporter, since most regulators accept a WHO-GMP + COPP dossier from an Indian manufacturing partner rather than requiring your own inspected facility.

No — each country (Nigeria, Kenya, Tanzania, Ghana, Uganda, Ethiopia, South Africa and others) maintains its own regulator, dossier requirements and timeline. We confirm the specific pathway for your target country before quoting.

Typical Buyer Types

  • Licensed importers and wholesalers
  • Hospital groups
  • Ministry of health / government tenders
  • NGOs and donor-funded procurement programmes
Requirements vary by product and destination. This page describes the general market landscape, not company-specific sales coverage or a guarantee of registration outcome.
Request a Quote for Africa

Related Products for This Market

Ready to Source for Africa?

Get an Export QuoteView Compliance Framework
Get a Quote